Company Filing History:

6 out of 1,777

Novo Nordisk A/s

patents

2 out of 28

Pronova Biopharma Norge As

Pronova Biopharm Norge As

patent

Years Active: 1997-2022

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11523999 - Compositions comprising a fatty aged oil mixture and a free fatty acid, and methods and uses thereof (2022-12-13),

2. 10596142 - Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof (2020-03-24),

3. 10028928 - Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof (2018-07-24),

4. 7217433 - Animal feed additives (2007-05-15),

5. 6245546 - Animal feed additives (2001-06-12),

6. 6080567 - Enzymes with xylanase activity from Aspergillus aculeatus (2000-06-27),

7. 5885819 - Enzyme with xylanase activity (1999-03-23),

8. 5874274 - Processing plant material with xylanase (1999-02-23),

9. 5817500 - Animal feed additives (1998-10-06),

10. 5693518 - Enzymes with xylanase activity from Aspergillus aculeatus (1997-12-02),

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide valuable information about inventor Anette Mullertz, a man from Charlottenlund, DK, who holds 10 patents. Let's dive into his remarkable journey and contributions to the field of inventions.

**Title: The Innovator Extraordinaire: Anette Mullertz**

Introduction:

Anette Mullertz is a visionary inventor based in Charlottenlund, Denmark, whose passion for groundbreaking discoveries has led to the creation of numerous pioneering patents in the field of drug delivery systems.

Latest Patents:

Anette Mullertz's latest patents showcase his expertise in developing compositions comprising a fatty acid oil mixture and free fatty acids, along with innovative methods and uses for these compositions. These patents also reveal his advancements in creating preconcentrates capable of forming self-nanoemulsifying drug delivery systems, self-microemulsifying drug delivery systems, and self-emulsifying drug delivery systems in an aqueous solution. The preferred fatty acids include eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in forms such as ethyl ester and triglyceride.

Career Highlights:

Throughout his career, Anette Mullertz has made significant contributions to companies such as Novo Nordisk A/S and Pronova Biopharma Norge AS. His innovative mindset and relentless pursuit of excellence have undoubtedly shaped the landscape of drug delivery systems within these renowned organizations.

Collaborations:

Anette Mullertz has had the privilege of collaborating with esteemed professionals in the industry, including Lene Venke Kofod and Hans Peter Heldt-Hansen. Together, they have combined their expertise to push the boundaries of innovation and pave the way for future advancements in the field.

Conclusion:

In conclusion, Anette Mullertz's innovative spirit, coupled with his unparalleled dedication to creating cutting-edge drug delivery systems, has solidified his position as a trailblazing inventor in the realm of patents. His remarkable contributions continue to inspire and drive progress within the industry, leaving a lasting impact on the future of pharmaceutical innovation.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.